BrainsWay Ltd.

BRSYF ·Healthcare, Medical Devices, Israel
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017
Revenue $41.0M $31.8M $27.2M $29.7M $22.1M $23.1M $16.4M $11.1M
Cost of Revenue $10.4M $8.3M $7.1M $6.6M $5.1M $5.1M $3.6M $2.6M
Gross Profit $30.6M $23.5M $20.0M $23.1M $17.0M $18.0M $12.8M $8.6M
Gross Margin 74.6% 73.9% 73.8% 77.7% 77.1% 77.8% 78.1% 76.7%
Operating Expenses
Research & Development — — — — — — — —
SG&A Expense — — — — — — — —
Operating Income $1.4M $-5.0M $-12.7M $-5.0M $-4.8M $-8.5M $-5.1M $-6.6M
Operating Margin 3.4% -15.6% -46.7% -16.9% -21.9% -36.7% -31.2% -59.3%
Interest Expense — — — — — — — —
Pretax Income $3.5M $-3.9M $-13.0M $-6.4M $-5.1M $-9.9M $-6.3M $-6.9M
Income Tax Expense $538.0K $251.0K $315.0K $43.0K $237.0K $422.0K $209.0K $169.0K
Net Income $2.9M $-4.2M $-13.3M $-6.5M $-5.4M $-10.3M $-6.5M $-7.1M
Net Margin 7.1% -13.2% -49.1% -21.8% -24.4% -44.7% -39.5% -63.3%
EPS (Basic) $0.09 $-0.13 $-0.40 $-0.21 — — — —
EPS (Diluted) $0.05 $-0.13 $-0.40 $-0.21 — — — —
Shares Outstanding (Basic) 37.6M 33.2M 33.1M 32.9M 22.3M 22.2M — —
Shares Outstanding (Diluted) 37.6M 33.2M 33.1M 32.9M 22.3M 22.2M — —
Dividends Per Share — — — — — — — —